Liver fibrosis caused by choledocholith to regress after biliary drainage.

Aim: To study the correlation between liver fibrosis severity and biliary drainage in patients with choledocholith.

Methods: A follow-up study on seven patients with liver fibrosis due to choledocholith was made. The data, including biochemical tests (aspartate aminotransferase, alanine aminotransferase) and liver histological features before and after biliary drainage, were collected and studied.

Regression of liver fibrosis after biliary drainage in patients with choledocholith: a preliminary report.

Background: Choledocholith is prevalent in some Asian countries and may lead to liver fibrosis and portal vein hypertension. Biliary drainage is an effective treatment for choledocholith. The aim of this study was to assess the impact of biliary drainage on liver fibrosis due to choledocholith.